ROLE OF MECHANICAL AND HORMONAL FACTORS IN CARDIAC REMODELING AND THE BIOLOGIC LIMITS OF MYOCARDIAL ADAPTATION

被引:41
作者
KLUG, D [1 ]
ROBERT, V [1 ]
SWYNGHEDAUW, B [1 ]
机构
[1] HOP CARDIOL, SERV CARDIOL A, F-59037 LILLE, FRANCE
关键词
D O I
10.1016/0002-9149(93)90245-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with chronic congestive heart failure manifest greater-than-or-equal-to 1 of the following abnormalities: diastolic dysfunction, systolic dysfunction, and arrhythmias. Diastolic dysfunction, one of the first symptoms to occur during hypertensive cardiopathy, depends on both active relaxation of the cardiac muscle and passive ventricular compliance. The ability of the ventricles to relax depends on normal calcium metabolism and adenosine triphosphate concentration. Ability to extrude intracellular calcium is depressed in the hypertrophied, overloaded heart as compared with the normal myocardium. Myocardial fibrosis is the major cause of increased diastolic ventricular stiffness. Left ventricular (LV) hypertrophy and myocardial fibrosis also greatly increase the likelihood of ventricular arrhythmias, in particular by prolonging the QRS interval and facilitating the occurrence of reentry arrhythmias. Findings in animal studies have indicated that such fibrosis, which involves excessive collagen deposition, is independent of LV hypertrophy and that LV hypertrophy does not necessarily result in myocardial fibrosis. Instead, the development of myocardial fibrosis is sensitive to circulating levels of both angiotensin II and aldosterone, and the fibrotic response to each of these substances is independent. The aldosterone antagonist spironolactone prevents myocardial fibrosis in several animal models, thus confirming the importance of aldosterone in the genesis of excessive collagen deposition.
引用
收藏
页码:A46 / A54
页数:9
相关论文
共 76 条
[1]   ANALYSIS OF THE MINERALOCORTICOID RECEPTOR IN RAT-HEART WITH THE AID OF 2 NEW SPIROLACTONE DERIVATIVES [J].
AGARWAL, MK ;
KALIMI, M .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1989, 41 (01) :36-45
[2]   CHARACTERIZATION OF OSCILLATIONS OF INTRACELLULAR CALCIUM-CONCENTRATION IN FERRET VENTRICULAR MUSCLE [J].
ALLEN, DG ;
EISNER, DA ;
ORCHARD, CH .
JOURNAL OF PHYSIOLOGY-LONDON, 1984, 352 (JUL) :113-128
[3]   INCREASED MYOTHERMAL ECONOMY OF ISOMETRIC FORCE GENERATION IN COMPENSATED CARDIAC-HYPERTROPHY INDUCED BY PULMONARY-ARTERY CONSTRICTION IN THE RABBIT - A CHARACTERIZATION OF HEAT LIBERATION IN NORMAL AND HYPERTROPHIED RIGHT VENTRICULAR PAPILLARY-MUSCLES [J].
ALPERT, NR ;
MULIERI, LA .
CIRCULATION RESEARCH, 1982, 50 (04) :491-500
[4]   ALTERED CALCIUM REGULATION IN THE CARDIAC PLASMA-MEMBRANE IN EXPERIMENTAL RENAL-HYPERTENSION [J].
ANDRAWIS, NS ;
KUO, TH ;
GIACOMELLI, F ;
WIENER, J .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1988, 20 (07) :625-634
[5]  
BELICHARD P, 1988, BASIC RES CARDIOL, V83, P560
[6]   EFFECT OF LATHYROGEN BETA-AMINO PROPRIONITRILE (BAPN) ON MECHANICAL-PROPERTIES OF EXPERIMENTALLY HYPERTROPHIED RAT CARDIAC-MUSCLE [J].
BING, OHL ;
FANBURG, BL ;
BROOKS, WW ;
MATSUSHITA, S .
CIRCULATION RESEARCH, 1978, 43 (04) :632-637
[7]   FIBER TYPES AND MYOSIN TYPES IN HUMAN ATRIAL AND VENTRICULAR MYOCARDIUM - AN ANATOMICAL DESCRIPTION [J].
BOUVAGNET, P ;
LEGER, J ;
PONS, F ;
DECHESNE, C ;
LEGER, JJ .
CIRCULATION RESEARCH, 1984, 55 (06) :794-804
[8]   RECENT ADVANCES IN THE IDENTIFICATION OF PATIENTS AT RISK OF VENTRICULAR TACHYARRHYTHMIAS - ROLE OF VENTRICULAR LATE POTENTIALS [J].
BREITHARDT, G ;
BORGGREFE, M .
CIRCULATION, 1987, 75 (06) :1091-1096
[9]   REMODELING OF THE RAT RIGHT-AND-LEFT-VENTRICLES IN EXPERIMENTAL-HYPERTENSION [J].
BRILLA, CG ;
PICK, R ;
TAN, LB ;
JANICKI, JS ;
WEBER, KT .
CIRCULATION RESEARCH, 1990, 67 (06) :1355-1364
[10]   DIFFERENCES IN BETA-ADRENERGIC NEUROEFFECTOR MECHANISMS IN ISCHEMIC VERSUS IDIOPATHIC DILATED CARDIOMYOPATHY [J].
BRISTOW, MR ;
ANDERSON, FL ;
PORT, JD ;
SKERL, L ;
HERSHBERGER, RE ;
LARRABEE, P ;
OCONNELL, JB ;
RENLUND, DG ;
VOLKMAN, K ;
MURRAY, J ;
FELDMAN, AM .
CIRCULATION, 1991, 84 (03) :1024-1039